U.S. stock market anomaly | New drug Kaijile is approved for listing in China, Ding Medicine (ZLAB.US) rises more than 7%

According to the Wise Finance app, on Wednesday, the stock price of Zai Ding Medicine (ZLAB.US) rose, with the stock up over 7% to $18.84 as of the time of publication. The stock also closed up 6.24% on the Hong Kong stock market today. In terms of news, Zai Ding Medicine announced that the National Medical Products Administration of China has approved the new drug market application for the bisnortimomerine clozapine capsule (Kaijiele) for the treatment of adult schizophrenia. This is the first schizophrenia therapy with a completely new mechanism of action to be approved in over 70 years, bringing a fundamental breakthrough to the treatment of schizophrenia.